Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Kerr

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
Infection and Immunity|April 12, 2017
Attenuated Phenotype of a Recent House Finch-Associated Mycoplasma gallisepticum Isolate in Domestic PoultryK Pflaum, E R Tulman, J Beaudet, et al.
Cancer|March 10, 2001
Primary pulmonary osteosarcoma: case report and molecular analysisA D Chapman, S C Pritchard, W W Yap, et al.
American Journal of Respiratory and Critical Care Medicine|August 3, 1999
Long-term outcome after pulmonary thromboendarterectomyC J Archibald, W R Auger, P F Fedullo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2023
Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upL E Hendriks, K M Kerr, J Menis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2023
Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upL E Hendriks, K M Kerr, J Menis, et al.
ESMO Open|June 25, 2023
Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementationJ R Gosney, L Paz-Ares, P Jänne, et al.
American Journal of Respiratory and Critical Care Medicine|July 21, 2000
The use of cylexin (CY-1503) in prevention of reperfusion lung injury in patients undergoing pulmonary thromboendarterectomyK M Kerr, W R Auger, J J Marsh, et al.
Thorax|June 1, 2004
Inter-observer variation between pathologists in diffuse parenchymal lung diseaseA G Nicholson, B J Addis, H Bharucha, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 22, 2024
Antibody-drug conjugates in lung and breast cancer: current evidence and future directions-a position statement from the ETOP IBCSG Partners FoundationS Peters, S Loi, F André, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2025
Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†A Zer, M-J Ahn, F Barlesi, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Infection and Immunity|April 12, 2017
Attenuated Phenotype of a Recent House Finch-Associated Mycoplasma gallisepticum Isolate in Domestic PoultryK Pflaum, E R Tulman, J Beaudet, et al.
Cancer|March 10, 2001
Primary pulmonary osteosarcoma: case report and molecular analysisA D Chapman, S C Pritchard, W W Yap, et al.
American Journal of Respiratory and Critical Care Medicine|August 3, 1999
Long-term outcome after pulmonary thromboendarterectomyC J Archibald, W R Auger, P F Fedullo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2023
Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upL E Hendriks, K M Kerr, J Menis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2023
Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upL E Hendriks, K M Kerr, J Menis, et al.
ESMO Open|June 25, 2023
Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementationJ R Gosney, L Paz-Ares, P Jänne, et al.
American Journal of Respiratory and Critical Care Medicine|July 21, 2000
The use of cylexin (CY-1503) in prevention of reperfusion lung injury in patients undergoing pulmonary thromboendarterectomyK M Kerr, W R Auger, J J Marsh, et al.
Thorax|June 1, 2004
Inter-observer variation between pathologists in diffuse parenchymal lung diseaseA G Nicholson, B J Addis, H Bharucha, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 22, 2024
Antibody-drug conjugates in lung and breast cancer: current evidence and future directions-a position statement from the ETOP IBCSG Partners FoundationS Peters, S Loi, F André, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2025
Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†A Zer, M-J Ahn, F Barlesi, et al.
Pageof 13